Balanced news tone
News Sentiment
MRK sentiment intelligence
Merck & Co., Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
54
Balanced news tone
34 relevant articles
Price is moving more forcefully than the current news tone suggests.
84/100 classification confidence.
directly relevant articles
high-authority source matches
+5.5% over one week, +16.8% over four weeks, trend active, and near fair-value range.
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Merck (NYSE:MRK)
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
84/100 classification
One-week reaction
5.5%
Price confirming higher
Trend fit
Trend active
16.8% over four weeks
Fair value
18.3%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
9
Neutral
22
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
PR Newswire
Direct company coverage
DELFI Diagnostics Announces Equity Investment from the Merck Global Health Innovation Fund to Accelerate DELFI's Cancer Screening AI Fragmentomics Platform
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2024 07:00
- Source
- PR Newswire
Reuters
Direct company coverage
Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 25 Apr 2024 07:00
- Source
- Reuters
Reuters
Direct company coverage
Merck seeks more deals to prepare for Keytruda's revenue decline
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 01 Feb 2024 08:00
- Source
- Reuters
Merck.com
Direct company coverage
Merck | Home
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Mar 2006 20:20
- Source
- Merck.com